Deepnoid Unveils Disease Diagnosis Support AI Solution at 'KCR 2024'

Deepnoid, a first-generation domestic medical artificial intelligence specialist company, will showcase its disease diagnosis support AI solution DEEP:AI at the '80th Korean Congress of Radiology (KCR)' held at COEX, Seoul, from the 2nd to the 5th of next month.

Through booth exhibitions, Deepnoid will present its major medical AI products. The exhibition items include ▲DEEP:NEURO, a brain aneurysm detection support AI solution ▲DEEP:CHEST, a lung disease detection support AI solution ▲DEEP:LUNG, a lung nodule detection support AI solution. Each product provides an optimized workflow for medical professionals and helps improve the accuracy and efficiency of interpretations.

At the exhibition, Deepnoid will share various clinical application cases and key research achievements of each product. It also plans to detail the clinical value and recently updated features of DEEP:NEURO, which has been selected as an innovative medical technology.

Choi Woosik, CEO of Deepnoid, said, "With DEEP:NEURO being selected as an innovative medical technology and officially entering the clinical market, we plan to increase contact points with more potential customers through this exhibition." He added, "Furthermore, based on DEEP:CHEST and DEEP:LUNG, which are also being showcased, we will strive to secure overseas clients to enable efficient diagnosis in domestic and international medical fields."

KCR is Asia's representative academic conference hosted by the Korean Society of Radiology, marking its 80th anniversary this year. KCR 2024 will be held under the slogan ‘Everlasting Evolution for Patient-centered Care,’ with approximately 3,800 radiology specialists and related personnel from 41 countries worldwide participating.

This content was produced with the assistance of AI translation services.